{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:03:44Z","timestamp":1773068624797,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To characterize patients with celiac disease (CD), examines the clinical spectrum of CD, and evaluate the performance of serologic tests used for CD screening, in the United Arab Emirates (UAE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Medical charts of patients received at the Digestive Diseases Institute of Cleveland Clinic Abu Dhabi from January 2015 to December 2020 were reviewed. Patients who were screened for four serologic biomarkers (anti-tissue transglutaminase IgA [Anti-tTG-IgA], anti-tissue transglutaminase IgG [Anti-TtG-IgG], anti-deamidated gliadin peptide IgG [Anti-DGP-IgG], and anti-deamidated gliadin peptide IgA [Anti-DGP-IgA]) were included. Histopathology was performed on patients with the seropositive test. Marsh score &amp;gt; 1 considered to confirm CD. Characteristics of the Anti-tTG-IgA seropositive patients were described and that correlated with histopathologically confirmed CD were explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 6,239 patients, 1.4, 2.9, 4.7, and 4.9%, were seropositive to Anti-tTG-IgG, Anti-TtG-IgA, Anti-DGP-IgA, and Anti-DGP-IgG, respectively. Overall, 7.7% were seropositive to either of the four biomarkers. Of the biopsy-screened 300 patients, 38.7% (1.9% of the total serologically screened) were confirmed with CD. The mean age of Anti-TtG-IgA seropositive patients was 32.1 \u00b1 10.3 SD years, 72% of them were females, and 93.4% were Emirati. In those patients, overweight (28.7%) and obesity (24.7%) were common while 5.8% of patients were underweight. Anemia prevalence was 46.7%, 21.3% had Gastroesophageal reflux disease (GERD), 7.7% with autoimmune thyroid disease, 5.5% (type 1), and 3.3% (type 2) were diabetic. Vitamin D deficiency was observed in 47.8% of the Anti-TtG IgA seropositive patients. Twelve (10.3%) histopathologically confirmed CD patients were seronegative to Anti-TtG-IgA but seropositive to anti-DGP-IgA and\/or Anti-DGP-IgG. Body mass index, GERD, autoimmune thyroid disease, type 1 diabetes, asthma, hemoglobin, and vitamin D concentration, were all correlated with biopsy-confirmed CD (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Compared to the gold-standard biopsy test, Anti-TtG-IgA had the highest sensitivity (89.7%) and specificity (83.7%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Three and two of every 100 patients were serologically (anti-tTG-IgA positive) and histopathologically diagnosed with CD, respectively. Although Anti-TtG-IgA is the most sensitive, specific, and commonly used test, one of every ten histopathologically confirmed patients and Anti-tTG-IgA seronegative were seropositive to Anti-DGP. To avoid missing patients with CD, a comprehensive serological investigation covering DGP-IgG\/IgA is warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2023.1107017","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T05:04:47Z","timestamp":1680671087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mode of presentation and performance of serology assays for diagnosing celiac disease: A single-center study in the United Arab Emirates"],"prefix":"10.3389","volume":"10","author":[{"given":"Abdullah","family":"Shatnawei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma H.","family":"AlNababteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romona Devi","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saif","family":"Al-Shamsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar","family":"AlJarrah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami H.","family":"Al-Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10620-019-05528-3","article-title":"Diagnosis and treatment patterns in celiac disease.","volume":"64","author":"Cichewicz","year":"2019","journal-title":"Dig Dis Sci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10395","author":"Chou","year":"2017","journal-title":"U.S. Preventive Services Task Force Evidence Syntheses, Formerly Systematic Evidence Reviews. Screening for Celiac Disease: A Systematic Review for the US Preventive Services Task Force."},{"key":"B3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis.","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.autrev.2018.05.013","article-title":"Celiac disease and endocrine autoimmunity \u2013 the genetic link.","volume":"17","author":"Kahaly","year":"2018","journal-title":"Autoimmunity Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3121\/cmr.2007.738","article-title":"Celiac disease and autoimmune thyroid disease.","volume":"5","author":"Ch\u2019ng","year":"2007","journal-title":"Clin Med Res."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1684","article-title":"Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance.","volume":"338","author":"Richey","year":"2009","journal-title":"BMJ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"Clinical guidelines: diagnosis and management of celiac disease.","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Off J Am Coll Gastroenterol ACG."},{"key":"B8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00261-016-1034-y","article-title":"Celiac disease: a clinical review.","volume":"42","author":"Al-Bawardy","year":"2017","journal-title":"Abdominal Radiol.."},{"key":"B9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12016-018-8691-2","article-title":"Comprehensive review of celiac disease\/gluten-sensitive enteropathies.","volume":"57","author":"McAllister","year":"2019","journal-title":"Clin Rev Allergy Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European society for the study of coeliac disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United Eur Gastroenterol J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","article-title":"Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology.","volume":"63","author":"Ludvigsson","year":"2014","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/diseases3020086","article-title":"Celiac disease: diagnostic standards and dilemmas.","volume":"3","author":"Kaswala","year":"2015","journal-title":"Diseases."},{"key":"B13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5546\/aap.2019.eng.52","article-title":"IgA anti-tissue transglutaminase antibodies and IgG antibodies against deamidated gliadin peptides as predictors of celiac disease.","volume":"117","author":"Ortiz","year":"2019","journal-title":"Arch Argent Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MPG.0b013e31824703c7","article-title":"Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.","volume":"55","author":"Mozo","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5001\/omj.2018.72","article-title":"Occurrence of hypothyroidism, diabetes mellitus, and celiac disease in emirati children with down\u2019s syndrome.","volume":"33","author":"Abdulrazzaq","year":"2018","journal-title":"Oman Med J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"15830","DOI":"10.3748\/wjg.v20.i42.15830","article-title":"Seroprevalence of celiac disease among United Arab Emirates healthy adult nationals: a gender disparity.","volume":"20","author":"Abu-Zeid","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B17","year":"2000","journal-title":"Obesity: Preventing and Managing the Global Epidemic."},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.seminhematol.2015.07.006","article-title":"Anemia in clinical practice-definition and classification: does hemoglobin change with aging?","volume":"52","author":"Cappellini","year":"2015","journal-title":"Semin Hematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0753-3322(01)80003-2","article-title":"Histopathology of celiac disease.","volume":"54","author":"Oberhuber","year":"2000","journal-title":"Biomed Pharmacother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/1319-3767.91733","article-title":"Serologic markers of gluten sensitivity in a healthy population from the western region of Saudi Arabia.","volume":"18","author":"Khayyat","year":"2012","journal-title":"Saudi J Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4536-1","article-title":"Prevalence of vitamin D deficiency and associated comorbidities among Abu Dhabi Emirates population.","volume":"12","author":"Al Zarooni","year":"2019","journal-title":"BMC Res Notes."},{"key":"B22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10620-017-4835-0","article-title":"Gender-based differences in a population-based cohort with celiac disease: more alike than unalike.","volume":"63","author":"Jansson-Knodell","year":"2018","journal-title":"Dig Dis Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3748\/wjg.v27.i20.2603","article-title":"Understanding celiac disease monitoring patterns and outcomes after diagnosis: a multinational, retrospective chart review study.","volume":"27","author":"Lundin","year":"2021","journal-title":"World J Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10620-006-9258-2","article-title":"The Canadian celiac health survey.","volume":"52","author":"Cranney","year":"2007","journal-title":"Dig Dis Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.cgh.2013.05.030","article-title":"Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea.","volume":"11","author":"Abu Daya","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/MPG.0000000000001634","article-title":"Celiac disease symptom resolution: effectiveness of the gluten-free diet.","volume":"66","author":"Sansotta","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jgh3.12073","article-title":"Anemia in celiac disease is multifactorial in etiology: a prospective study from India.","volume":"2","author":"Berry","year":"2018","journal-title":"JGH Open."},{"key":"B28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12664-012-0198-9","article-title":"Clinical presentation of celiac disease among pediatric compared to adolescent and adult patients.","volume":"31","author":"Kochhar","year":"2012","journal-title":"Indian J Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/nu13051695","article-title":"Iron deficiency anemia in celiac disease.","volume":"13","author":"Talarico","year":"2021","journal-title":"Nutrients."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112557","article-title":"Multifactorial etiology of anemia in celiac disease and effect of gluten-free diet: a comprehensive review.","volume":"11","author":"Mart\u00edn-Masot","year":"2019","journal-title":"Nutrients."},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2036.2009.04110.x","article-title":"Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease.","volume":"31","author":"Lewis","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s10620-017-4474-5","article-title":"Diagnostic yield of isolated deamidated gliadin peptide antibody elevation for celiac disease.","volume":"62","author":"Hoerter","year":"2017","journal-title":"Dig Dis Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jama.2017.1462","article-title":"Screening for celiac disease: US preventive services task force recommendation statement.","volume":"317","author":"Us Preventive Services Task Force, Bibbins-Domingo","year":"2017","journal-title":"JAMA."},{"key":"B34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1177\/2050640613502788","article-title":"Serological testing for celiac disease in adults.","volume":"1","author":"Schyum","year":"2013","journal-title":"United Eur Gastroenterol J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MPG.0000000000001216","article-title":"NASPGHAN clinical report on the diagnosis and treatment of gluten-related disorders.","volume":"63","author":"Hill","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/2050640615569379","article-title":"Prevalence estimation of celiac disease in the general adult population of Latvia using serology and HLA genotyping.","volume":"3","author":"Leja","year":"2015","journal-title":"United Eur Gastroenterol J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/MPG.0000000000002109","article-title":"In screening for celiac disease, deamidated gliadin rarely predicts disease when tissue transglutaminase is normal.","volume":"68","author":"Gould","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2036.2010.04337.x","article-title":"Antibodies against deamidated gliadin peptide (DGP) identifies adult celiac disease patients negative for antibodies against endomysium and tissue transglutaminase (tTG).","volume":"32","author":"Dahle","year":"2010","journal-title":"Aliment Pharmacol Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.32074\/1591-951X-157","article-title":"Celiac disease: histology-differential diagnosis-complications. A practical approach.","volume":"112","author":"Villanacci","year":"2020","journal-title":"Pathologica."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1107017\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T05:04:50Z","timestamp":1680671090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1107017\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":39,"alternative-id":["10.3389\/fnut.2023.1107017"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1107017","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"article-number":"1107017"}}